Title : Circulating prostaglandin E2: a novel potential prognostic biomarker in patients with hepatocellular carcinoma.

Pub. Date : 2021 Nov

PMID : 33768340






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. Dinoprostone monoglyceride lipase Homo sapiens
2 We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. Dinoprostone monoglyceride lipase Homo sapiens
3 We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. Dinoprostone monoglyceride lipase Homo sapiens
4 We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. Dinoprostone monoglyceride lipase Homo sapiens
5 We aimed to explore the activation of monoacylglycerol lipase (MAGL)/cyclooxygenase-2 (COX-2)/prostaglandin E2 (PGE2) axis in hepatocellular carcinoma (HCC), evaluating circulating PGE2 as prognostic biomarker in HCC patients. Dinoprostone monoglyceride lipase Homo sapiens
6 The MAGL/COX-2/PGE2 axis is activated in HCC, and circulating PGE2 proved to be a potential prognostic biomarker. Dinoprostone monoglyceride lipase Homo sapiens